Comparison of PRP & DFDBA vs. DFDBA in Intrabony Periodontal Defects

Sponsor
Government Dental College and Hospital, India (Other)
Overall Status
Completed
CT.gov ID
NCT05886699
Collaborator
(none)
13
1
2
23
0.6

Study Details

Study Description

Brief Summary

The purpose of this clinical trial is to compare the results in subjects with periodontitis using subjects own blood - Platelet-rich plasma (PRP) combined with bone graft material, namely, Demineralized Freeze - Dried Bone Allograft (DFDBA) or DFDBA alone in the treatment of bone defects around the teeth.

Condition or Disease Intervention/Treatment Phase
  • Other: PRP combined with DFDBA
  • Other: DFDBA
N/A

Detailed Description

After being informed about the study and potential risks, 13 patients giving written informed consent and who meet the eligibility requirements were randomly allocated in a single blind manner (participants) to test group (PRP combined with DFDBA) or control group (DFDBA).

33 sites (18 test, 15 control unpaired defects) were treated - 1) to investigate the possible additional effects of PRP when combined with DFDBA, and 2) to compare the clinical and radiographic outcomes obtained in test and control groups,12 months post - operatively.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparison of Efficacy of Autologous Platelet - Rich Plasma Combined With Demineralized Freeze - Dried Bone Allograft Versus Demineralized Freeze - Dried Bone Allograft: A Randomized Clinical Trial in Central India
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: PRP combined with DFDBA

Open flap debridement, followed by placement of PRP combined with DFDBA

Other: PRP combined with DFDBA
Periodontal intrabony defects were treated with open flap debridement followed by placement of PRP combined with DFDBA

Active Comparator: DFDBA

Open flap debridement, followed by placement of DFDBA

Other: DFDBA
Periodontal intrabony defects were treated with open flap debridement followed by placement of PRP combined with DFDBA

Outcome Measures

Primary Outcome Measures

  1. Change in Probing Pocket Depth (PPD) from baseline to 12 months [baseline to 12 months]

    PPD is vertical measurement from the free gingival margin to the base of the pocket measured to the nearest millimeter using a UNC (University of North Carolina) -15 periodontal probe.

  2. Change in Periodontal Attachment Level (PAL) from baseline to 12 months [baseline to 12 months]

    PAL is vertical measurement recorded with the help of customized acrylic stent from a fixed reference point to the base of the pocket measured to the nearest millimeter using UNC - 15 probe

  3. Change in Gingival Recession (GR) from baseline to 12 months [baseline to 12 months]

    GR is vertical measurement recorded with the help of customized acrylic stent from a fixed reference point to the gingival margin measured to the nearest millimeter using UNC-15 probe

  4. Change in Crestal bone resorption from baseline to 12 months [baseline to 12 months]

    Crestal bone resorption is the distance from Cementoenamel Junction to the Alveolar Crest (CEJ- AC); measured in millimeters using standardized intraoral periapical (IOPA) radiographs along with a calibrated grid of the tooth of interest

  5. Change in Defect fill from baseline to 12 months [baseline to 12 months]

    Defect fill is the distance from Cementoenamel Junction to Base of the Defect (CEJ- BD); measured in millimeters using standardized intraoral periapical (IOPA) radiographs along with a calibrated grid of the tooth of interest

  6. Change in Defect resolution from baseline to 12 months [baseline to 12 months]

    Defect resolution is the distance from the Alveolar Crest to Base of the Defect (AC - BD); measured in millimeters using standardized intraoral periapical (IOPA) radiographs along with a calibrated grid of the tooth of interest

Secondary Outcome Measures

  1. Plaque Index [baseline to 12 months]

    Silness and Loe, 1964

  2. Gingival Index [baseline to 12 months]

    Loe and Silness, 1963

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Outpatients

  • with chronic periodontitis

  • who were free of local or systemic disease

  • who had not received any type of periodontal therapy in the last six months

  • radiograph showing at least one angular defect in any quadrant

  • the involved teeth were vital and asymptomatic

  • the site of interest had at least 2 mm of keratinized gingiva on the facial aspect of the selected teeth

Exclusion Criteria:
  • Patients with abnormal platelet count

  • allergic to chlorhexidine or any other medicine used in the study

  • showing unacceptable oral hygiene compliance during / after the phase I therapy;

  • pregnant or lactating mothers;

  • smokers

  • endodontically involved teeth

  • patients under any medication known to interfere with periodontal healing. e.g., corticosteroids

  • on anticoagulant therapy

  • patients with transferable jobs or who were uncooperative

  • patients participating in other dental clinical trials.

Contacts and Locations

Locations

Site City State Country Postal Code
1 212, Department of Periodontology, Government Dental college and Hospital Nagpur Maharashtra India 440003

Sponsors and Collaborators

  • Government Dental College and Hospital, India

Investigators

  • Principal Investigator: Pallavi A Meshram, MDS, Government Dental College and Hospital, Nagpur, India
  • Study Chair: Ramreddy K Yeltiwar, MDS, Rungta College of Dental Sciences and Research, Bhilai, India.
  • Study Director: Mangesh B Phadnaik, MDS, Government Dental College and Hospital, Nagpur, India

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Pallavi Meshram, Assistant Professor, Government Dental College and Hospital, India
ClinicalTrials.gov Identifier:
NCT05886699
Other Study ID Numbers:
  • PMeshram
First Posted:
Jun 2, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Dr. Pallavi Meshram, Assistant Professor, Government Dental College and Hospital, India
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2023